Suchergebnisse - "Bilgicer, Basar"

PubPharm (97)

1

Allergen-specific IgE inhibitors block anaphylactic responses by targeting allergen recognition

enthalten in: The Journal of allergy and clinical immunology | 2024

von Bilgicer, B. | Kaplan, M.

2

A nanotherapeutic approach to selectively eliminate metastatic breast cancer cells by targeting cell surface GRP78

enthalten in: Nanoscale | 2023

von Shin, J. | Kim, B. | Lager, T. | +6

3

Peanut allergen inhibition prevents anaphylaxis in a humanized mouse model

enthalten in: Science translational medicine | 2023

von Alakhras, N. | Shin, J. | Smith, S. | +8

4

Disease-driven engineering of peptide-targeted DM1 loaded liposomal nanoparticles for enhanced efficacy in treating multiple myeloma by exploring DM1 prodrug chemistry

enthalten in: Biomaterials | 2023

von Khan, S. | Mejia, F. | Shin, J. | +6

5

Determination of immunogenic epitopes in major house dust mite allergen, Der p 2, via nanoallergens

enthalten in: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology | 2022

von Sjoerdsma, J. | Mejia, F. | Bilgicer, B.

CommentIn: Ann Allergy Asthma Immunol. 2022 Aug;129(2):133. - PMID 35878956

6

Mouse pulmonary interstitial macrophages mediate the pro-tumorigenic effects of IL-9

enthalten in: Nature communications | 2022

von Fu, Y. | Pajulas, A. | Wang, J. | +24

7

Liposomal Targeting Modifies Endosomal Escape : Design and Mechanistic Implications

enthalten in: ACS biomaterials science & engineering | 2022

von Mejia, F. | Khan, S. | Bilgicer, B.

8

Identification and optimization of tunable endosomal escape parameters for enhanced efficacy in peptide-targeted prodrug-loaded nanoparticles

enthalten in: Nanoscale | 2022

von Mejia, F. | Khan, S. | Omstead, D. | +2

9

In vivo evaluation of CD38 and CD138 as targets for nanoparticle-based drug delivery in multiple myeloma

enthalten in: Journal of hematology & oncology | 2020

von Omstead, D. | Mejia, F. | Sjoerdsma, J. | +7

10

In vivo evaluation of CD38 and CD138 as targets for nanoparticle-based drug delivery in multiple myeloma

enthalten in: Journal of hematology & oncology | 2020

von Omstead, D. | Mejia, F. | Sjoerdsma, J. | +7

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]